Article: Isoniazid induced encephalopathy in dialysis patients

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleIsoniazid induced encephalopathy in dialysis patients
AuthorsCheung, WC1
Lo, CY1
Lo, WK1
Ip, M1
Cheng, IKP1
Issue Date1993
PublisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/tube
CitationTubercle And Lung Disease, 1993, v. 74 n. 2, p. 136-139 [How to Cite?]
DOI: http://dx.doi.org/10.1016/0962-8479(93)90042-V
AbstractThree dialysis patients with extrapulmonary tuberculosis developed confusion 4-14 days after commencement of treatment with anti-tuberculosis drugs, despite the use of prophylactic pyridoxine. Full recovery of conscious state resulted within 1 week in all patients after stopping isoniazid. In 2 patients confusion recurred on rechallenge of the drug. The risk factors of isoniazid induced encephalopathy and the dosage of isoniazid in uraemic patients were discussed.
ISSN0962-8479
DOIhttp://dx.doi.org/10.1016/0962-8479(93)90042-V
DC Field
Value
dc.contributor.authorCheung, WC
dc.contributor.authorLo, CY
dc.contributor.authorLo, WK
dc.contributor.authorIp, M
dc.contributor.authorCheng, IKP
dc.date.accessioned2012-09-05T05:16:34Z
dc.date.available2012-09-05T05:16:34Z
dc.date.issued1993
dc.description.abstractThree dialysis patients with extrapulmonary tuberculosis developed confusion 4-14 days after commencement of treatment with anti-tuberculosis drugs, despite the use of prophylactic pyridoxine. Full recovery of conscious state resulted within 1 week in all patients after stopping isoniazid. In 2 patients confusion recurred on rechallenge of the drug. The risk factors of isoniazid induced encephalopathy and the dosage of isoniazid in uraemic patients were discussed.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationTubercle And Lung Disease, 1993, v. 74 n. 2, p. 136-139 [How to Cite?]
DOI: http://dx.doi.org/10.1016/0962-8479(93)90042-V
dc.identifier.doihttp://dx.doi.org/10.1016/0962-8479(93)90042-V
dc.identifier.epage139
dc.identifier.issn0962-8479
dc.identifier.issue2
dc.identifier.pmid8324207
dc.identifier.scopuseid_2-s2.0-0027460873
dc.identifier.spage136
dc.identifier.urihttp://hdl.handle.net/10722/162001
dc.identifier.volume74
dc.languageeng
dc.publisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/tube
dc.publisher.placeUnited Kingdom
dc.relation.ispartofTubercle and Lung Disease
dc.subject.meshAdult
dc.subject.meshConfusion - Chemically Induced - Prevention & Control
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIsoniazid - Adverse Effects
dc.subject.meshKidney Failure, Chronic - Complications
dc.subject.meshMiddle Aged
dc.subject.meshPyridoxine - Therapeutic Use
dc.subject.meshRenal Dialysis
dc.subject.meshTuberculosis - Complications
dc.titleIsoniazid induced encephalopathy in dialysis patients
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong